Magnesium%2525252525252525252525252525252525252525252525252520sulfate

# Magnesium%2525252525252525252525252525252525252525252525252520sulfate ## Overview Magnesium sulfate is an essential mineral and electrolyte that plays a crucial role in numerous biochemical reactions. It is available for intravenous (IV) and intramuscular (IM) administration, as well as oral and topical formulations, though IV/IM are most common in acute care settings. ## Primary Indications * **Hypomagnesemia:** Treatment of low magnesium levels. * **Eclampsia/Preeclampsia:** Prevention and treatment of seizures in pregnant patients with severe preeclampsia or eclampsia. * **Torsades de Pointes:** Treatment of polymorphic ventricular tachycardia associated with a prolonged QT interval. * **Bronchodilation:** Adjunctive therapy in severe, acute bronchospasm (e.g., asthma exacerbation). * **Constipation:** Oral formulations are used as a laxative. ## Adult Dosing Dosing is highly variable based on indication and local protocols. * **Hypomagnesemia:** * **Severe:** Typically a loading dose followed by a maintenance infusion. A common regimen is 4-6 grams IV over 5-60 minutes (loading dose), followed by 1-2 grams per hour IV infusion (maintenance). Doses can be adjusted based on serum magnesium levels and clinical response. * **Mild/Moderate:** May be given IM (e.g., 1 gram q6h for 4 doses) or as a slower IV infusion. * **Eclampsia/Preeclampsia:** A standard regimen (e.g., the Pritchard regimen) involves a loading dose of 4-6 grams IV over 5-20 minutes, followed by a maintenance infusion of 1-2 grams per hour. Alternative regimens exist. * **Torsades de Pointes:** Typically 1-2 grams IV diluted in 10 mL of D5W administered rapidly over 5-10 minutes. This may be followed by an infusion of 0.5-1 gram per hour. * **Bronchodilation:** 1-2 grams IV diluted in 100 mL of normal saline or D5W infused over 15-30 minutes. ## Pediatric Dosing Dosing in pediatrics is less standardized and often weight-based. Serum magnesium levels and clinical response are critical. Exact dosing should follow institutional guidelines or expert consultation. * **Hypomagnesemia:** * Loading doses can range from 25-100 mg/kg IV, not to exceed 2 grams, given over 10-20 minutes. * Maintenance infusions can range from 10-50 mg/kg/hour IV, not to exceed 6 grams/day. * **Asthma:** Dosing is variable, often 25-40 mg/kg IV over 10-20 minutes. ## Dose Adjustments * **Renal Impairment:** Magnesium is renally excreted. Dose reduction and increased monitoring are necessary in patients with impaired renal function. Patients with anuria may not tolerate any supplemental magnesium. ## Contraindications * Hypermagnesemia. * Heart block (unless a pacemaker is in place). * Myocardial infarction. * Profound myocardial damage. ## Adverse Effects Common adverse effects are related to vasodilation and magnesium's effects on the neuromuscular junction and CNS. * **Most Common:** Flushing, warmth, hypotension, decreased deep tendon reflexes, lethargy, somnolence, nausea, vomiting. * **Serious:** Respiratory depression, cardiac arrhythmias, cardiac arrest, hypermagnesemia (manifested by absent reflexes, severe hypotension, respiratory depression, ECG changes, coma). ## Key Drug Interactions * **Calcium Salts:** IV calcium may be given to counteract magnesium-induced cardiac depression, but should be administered cautiously. * **Neuromuscular Blockers:** Magnesium can potentiate the effects of neuromuscular blocking agents, leading to prolonged neuromuscular blockade. * **Tetracyclines and Fluoroquinolones:** Oral magnesium can decrease the absorption of these antibiotics; administer at least 2 hours before or 4-6 hours after magnesium. * **Bisphosphonates:** Oral magnesium can decrease the absorption of bisphosphonates; administer at least 2 hours before magnesium. * **Digoxin:** Hypermagnesemia can increase the risk of digoxin toxicity. ## Monitoring * **Serum Magnesium Levels:** Essential, especially with IV infusions. Frequency depends on dose, infusion rate, renal function, and clinical status (e.g., every 4-6 hours initially, then less often if stable). Target levels vary by indication. * **Renal Function (BUN, Creatinine):** Monitor at baseline and periodically. * **Deep Tendon Reflexes:** Assess regularly as an indicator of magnesium toxicity. * **Respiratory Rate and Effort:** Monitor for signs of respiratory depression. * **Blood Pressure:** Monitor for hypotension. * **Cardiac Monitoring:** Consider for patients receiving high doses or at risk for arrhythmias. * **Urine Output:** Adequate renal function is crucial for magnesium excretion. ## Clinical Pearls * Magnesium sulfate is often administered as a 50% solution (500 mg/mL). When preparing infusions, consider the total volume and concentration. * Rapid IV administration can cause hypotension, flushing, and cardiac dysrhythmias. Dilute and infuse slowly as indicated by the clinical scenario. * IM injections can be painful; consider dilution or lidocaine in the same syringe (check compatibility). Limit IM doses to 2 grams per site due to risk of local irritation and tissue damage. * In hypomagnesemia, remember to correct hypokalemia and hypocalcemia concurrently, as these electrolyte disturbances are often interrelated. * Always confirm the concentration and intended route of administration before giving magnesium sulfate. *** **Disclaimer:** This information is intended for healthcare professionals and is a summary. It is not exhaustive. Always consult the most current prescribing information, institutional protocols, and clinical guidelines before initiating or modifying therapy.